BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33555613)

  • 1. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
    Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
    J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia.
    Alhaddad ZA; AlMousa HA; Younis NS
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists.
    Edris A; Vanoverschelde A; Bushaj P; Van Nieuwerburgh F; Lahousse L
    Pharmacogenomics J; 2021 Feb; 21(1):78-84. PubMed ID: 32848197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 8. Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand.
    Karuna N; Tragulpiankit P; Mahasirimongkol S; Chumnumwat S
    Pharmacogenet Genomics; 2020 Jun; 30(4):73-80. PubMed ID: 32187156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2018 Aug; 43(4):500-506. PubMed ID: 29722046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
    Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
    Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability.
    Wen YF; Jacobson PA; Oetting WS; Pereira C; Brown JT
    Pharmacogenomics; 2022 Nov; 23(16):873-885. PubMed ID: 36314296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics courses in pharmacy school curricula.
    Haga SB; Moaddeb J
    Pharmacogenomics; 2019 Jun; 20(9):625-630. PubMed ID: 31250728
    [No Abstract]   [Full Text] [Related]  

  • 14. An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.
    Mehtar M; Hammoud SH; Amin MEK
    Saudi Pharm J; 2022 Dec; 30(12):1765-1772. PubMed ID: 36601506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
    Tuteja S; Haynes K; Zayac C; Sprague JE; Bernhardt B; Pyeritz R
    Per Med; 2013 Nov; 10(8):793-800. PubMed ID: 24409195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
    Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
    J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nation-Wide Survey Assessing the Knowledge and Attitudes of Romanian Pharmacists Concerning Pharmacogenetics.
    Pop C; Cristina A; Iaru I; Popa SL; Mogoșan C
    Front Pharmacol; 2022; 13():952562. PubMed ID: 35847030
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Pharmacists' Involvement in Pharmacogenomics Testing and Related Services in China.
    Hu X; Jia T; Zhang X; Wu C; Zhang Y; Chen J; Guan X; Shi L; Lu CY; Nie X
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.